{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T14:59:08Z","timestamp":1781362748356,"version":"3.54.1"},"reference-count":30,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T00:00:00Z","timestamp":1656547200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>Patients with colorectal cancer have a high risk of iron deficiency anaemia (IDA) due to chronic tumour induced blood loss, a reduced dietary iron intake from poor nutrition or gastrointestinal malabsorption. This pilot, double blinded, randomised controlled trial (RCT) examined the effect and feasibility of using preoperative iron isomaltoside for treating iron deficiency anaemia.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods<\/jats:title>\n<jats:p>Forty eligible adults with IDA were randomised to receive either intravenous iron isomaltoside (20 mg.kg<jats:sup>-1<\/jats:sup> up to 1000 mg over 30 minutes) or usual preoperative care (control) three weeks before scheduled colorectal surgery. The primary outcomes were perioperative changes in haemoglobin and ferritin concentrations.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>The recruitment rate was 78% of all eligible referred patients (1.9 patients\/month). The haemoglobin and ferritin concentrations were higher in the iron isomaltoside group than the control group over the perioperative period (group*time interaction <jats:italic>P<\/jats:italic> = 0.042 and <jats:italic>P<\/jats:italic> &lt; 0.001 respectively). Mean haemoglobin change from baseline to before surgery was higher in the iron isomaltoside group (7.8, 95% CI: 3.2 to 12.3 g.l<jats:sup>-1<\/jats:sup>) than the control group (1.7, 95% CI: -1.9 to 5.3 g.l<jats:sup>-1<\/jats:sup>) [mean difference 6.1, 95% CI: 0.3 to 11.8 g.l<jats:sup>-1<\/jats:sup>; <jats:italic>P<\/jats:italic> = 0.040]. The ferritin change from baseline to before surgery between groups was large in favour of the iron isomaltoside group (mean difference 296.9, 95% CI: 200.6 to 393.2 \u03bcg.l<jats:sup>-1<\/jats:sup>; <jats:italic>P<\/jats:italic> &lt; 0.001]. There were no differences between groups in packed red blood cell transfusions needed, surgical complications, quality of recovery and days (alive and) at home within 30 days after surgery.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusion<\/jats:title>\n<jats:p>Iron isomaltoside therapy was safe and had a minimal effect on perioperative changes in haemoglobin concentration. Given the slow recruitment and new evidence emerging during the conduct of this study, conducting a multi-centre RCT based on the current pilot trial protocol is unlikely to be feasible.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec005\">\n<jats:title>Trial registration<\/jats:title>\n<jats:p>ClinicalTrials.gov <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03565354\" xlink:type=\"simple\">NCT03565354<\/jats:ext-link>.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0270640","type":"journal-article","created":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T17:42:50Z","timestamp":1656610970000},"page":"e0270640","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":19,"title":["Perioperative changes in haemoglobin and ferritin concentrations from preoperative intravenous iron isomaltoside for iron deficiency anaemia in patients with colorectal cancer: A pilot randomised controlled trial"],"prefix":"10.1371","volume":"17","author":[{"given":"Pui Lam Polly","family":"Fung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian Nga Man","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Floria Fung","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wing Wa","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony Wing Chung","family":"Mak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2864-0045","authenticated-orcid":true,"given":"Anna","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2022,6,30]]},"reference":[{"key":"pone.0270640.ref001","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.","volume":"68","author":"F Bray","year":"2018","journal-title":"CA Cancer J Clin."},{"key":"pone.0270640.ref002","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1007\/s00384-017-2898-1","article-title":"The role of preoperative iron deficiency in colorectal cancer patients: prevalence and treatment","volume":"32","author":"MJ Wilson","year":"2017","journal-title":"Int J Colorect Dis"},{"key":"pone.0270640.ref003","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/anae.13840","article-title":"Pre-operative haemoglobin levels and iron status in a large multicentre cohort of patients undergoing major elective surgery","volume":"72","author":"M Mu\u00f1oz","year":"2017","journal-title":"Anaesthesia"},{"key":"pone.0270640.ref004","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bja\/aev165","article-title":"\u2019Fit to fly\u2019: overcoming barriers to preoperative haemoglobin optimization in surgical patients.","volume":"115","author":"M Mu\u00f1oz","year":"2015","journal-title":"Br J Anaesth"},{"key":"pone.0270640.ref005","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/SLA.0b013e31825b35d5","article-title":"Effects of allogeneic red blood cell transfusions on clinical outcomes in patients undergoing colorectal cancer surgery: a systematic review and meta-analysis","volume":"256","author":"AG Acheson","year":"2012","journal-title":"Ann Surg"},{"key":"pone.0270640.ref006","doi-asserted-by":"crossref","first-page":"13345","DOI":"10.1038\/s41598-018-31662-5","article-title":"The impact of blood transfusion on recurrence and mortality following colorectal cancer resection: a propensity score analysis of 4,030 patients.","volume":"8","author":"HL Wu","year":"2018","journal-title":"Sci Rep."},{"key":"pone.0270640.ref007","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2147\/IJNRD.S89704","article-title":"Efficacy and safety of iron isomaltoside (Monofer(\u00ae)) in the management of patients with iron deficiency anemia.","volume":"9","author":"PA Kalra","year":"2016","journal-title":"Int J Nephrol Renovasc Dis"},{"key":"pone.0270640.ref008","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/anae.13773","article-title":"International consensus statement on the peri-operative management of anaemia and iron deficiency.","volume":"72","author":"M Mu\u00f1oz","year":"2017","journal-title":"Anaesthesia"},{"key":"pone.0270640.ref009","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/bjs.6688","article-title":"Randomized clinical trial of preoperative intravenous iron sucrose to reduce blood transfusion in anaemic patients after colorectal cancer surgery","volume":"96","author":"TJ Edwards","year":"2009","journal-title":"Br J Surg"},{"key":"pone.0270640.ref010","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/SLA.0000000000001646","article-title":"The important role for intravenous iron in perioperative patient blood management in major abdominal Surgery: a randomized controlled trial","volume":"264","author":"B Froessler","year":"2016","journal-title":"Ann Surg"},{"key":"pone.0270640.ref011","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/bjs.10328","article-title":"Randomized clinical trial of preoperative oral versus intravenous iron in anaemic patients with colorectal cancer","volume":"104","author":"BD Keeler","year":"2017","journal-title":"Br J Surg"},{"key":"pone.0270640.ref012","doi-asserted-by":"crossref","first-page":"i5239","DOI":"10.1136\/bmj.i5239","article-title":"CONSORT 2010 statement: extension to randomised pilot and feasibility trials","volume":"355","author":"SM Eldridge","year":"2016","journal-title":"BMJ"},{"key":"pone.0270640.ref013","unstructured":"National Blood Authority Australia. Patient Blood Management Guidelines: Module 2 Perioperative (2012). Available at: https:\/\/www.blood.gov.au\/system\/files\/documents\/pbm-module-2.pdf (accessed 14th November 2021)"},{"key":"pone.0270640.ref014","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey","volume":"240","author":"D Dindo","year":"2004","journal-title":"Ann Surg"},{"key":"pone.0270640.ref015","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1097\/ALN.0b013e318289b84b","article-title":"Development and psychometric evaluation of a postoperative quality of recovery score: the QoR-15","volume":"118","author":"PA Stark","year":"2013","journal-title":"Anesthesiology"},{"key":"pone.0270640.ref016","doi-asserted-by":"crossref","first-page":"e015828","DOI":"10.1136\/bmjopen-2017-015828","article-title":"Validation of days at home as an outcome measure after surgery: a prospective cohort study in Australia.","volume":"7","author":"PS Myles","year":"2017","journal-title":"BMJ Open"},{"key":"pone.0270640.ref017","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/ALN.0000000000001158","article-title":"Minimal clinically important difference for three Quality of Recovery scales","volume":"125","author":"PS Myles","year":"2016","journal-title":"Anesthesiology"},{"key":"pone.0270640.ref018","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.bja.2019.07.020","article-title":"Systematic review and consensus definitions for the Standardised Endpoints in Perioperative Medicine initiative: patient-centred outcomes","volume":"123","author":"SR Moonesinghe","year":"2019","journal-title":"Br J Anaesth"},{"key":"pone.0270640.ref019","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1177\/0962280215588241","article-title":"Estimating the sample size for a pilot randomised trial to minimise the overall trial sample size for the external pilot and main trial for a continuous outcome variable.","volume":"25","author":"AL Whitehead","year":"2016","journal-title":"Stat Meth Med Res"},{"key":"pone.0270640.ref020","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1038\/ajg.2013.335","article-title":"A randomized, open-label, non-inferiority study of intravenous iron isomaltoside 1,000 (Monofer) compared with oral iron for treatment of anemia in IBD (PROCEED).","volume":"108","author":"W Reinisch","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"pone.0270640.ref021","article-title":"Preoperative intravenous iron to treat anaemia before major abdominal surgery (PREVENTT): a randomised, double-blind, controlled trial.","volume":"4","author":"T Richards","year":"2020","journal-title":"Lancet"},{"key":"pone.0270640.ref022","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13741-020-00146-4","article-title":"The impact of preoperative systemic inflammation on the efficacy of intravenous iron infusion to correct anaemia prior to surgery for colorectal cancer","volume":"9","author":"ST McSorley","year":"2020","journal-title":"Periop Med"},{"key":"pone.0270640.ref023","doi-asserted-by":"crossref","first-page":"j2513","DOI":"10.1136\/bmj.j2513","article-title":"Interpreting iron studies","volume":"357","author":"AU Kelly","year":"2017","journal-title":"BMJ"},{"key":"pone.0270640.ref024","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1177\/0310057X19838899","article-title":"Associations between non-anaemic iron deficiency and outcomes following surgery for colorectal cancer: An exploratory study of outcomes relevant to prospective observational studies","volume":"47","author":"LF Miles","year":"2019","journal-title":"Anaesth Intens Care"},{"key":"pone.0270640.ref025","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/vox.12278","article-title":"Intravenous iron isomaltoside 1000 (Monofer\u00ae) reduces postoperative anaemia in preoperatively non-anaemic patients undergoing elective or subacute coronary artery bypass graft, valve replacement or a combination thereof: a randomized double-blind placebo-controlled clinical trial (the PROTECT trial).","volume":"109","author":"PI Johansson","year":"2015","journal-title":"Vox Sang"},{"key":"pone.0270640.ref026","unstructured":"Australian and New Zealand Clinical Trials Registry. A prospective observational study to determine if non-anaemic iron deficiency increases the risk of poor post-operative outcome relative to an iron replete control in patients undergoing surgery for colorectal malignancy. 7 December 2018. Available at: https:\/\/www.anzctr.org.au\/Trial\/Registration\/TrialReview.aspx?id=376536 (accessed 10 November 2021)."},{"issue":"6","key":"pone.0270640.ref027","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1111\/anae.14659","article-title":"The impact of pre-operative intravenous iron on quality of life after colorectal cancer surgery: outcomes from the intravenous iron in colorectal cancer-associated anaemia (IVICA) trial.","volume":"74","author":"BD Keeler","year":"2019","journal-title":"Anaesthesia"},{"key":"pone.0270640.ref028","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.bja.2018.03.020","article-title":"Systematic review and consensus definitions for standardised endpoints in perioperative medicine: postoperative cancer outcomes","volume":"121","author":"DJ Buggy","year":"2018","journal-title":"Br J Anaesth"},{"key":"pone.0270640.ref029","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1097\/ALN.0000000000000586","article-title":"Measurement of disability-free survival after surgery","volume":"122","author":"MA Shulman","year":"2015","journal-title":"Anesthesiology"},{"key":"pone.0270640.ref030","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/anae.15268","article-title":"The end of the beginning: pre-operative intravenous iron and the PREVENTT trial.","volume":"76","author":"LF Miles","year":"2021","journal-title":"Anaesthesia"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0270640","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T17:43:14Z","timestamp":1656610994000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0270640"}},"subtitle":[],"editor":[{"given":"Farzad","family":"Taghizadeh-Hesary","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,6,30]]},"references-count":30,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,6,30]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0270640","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,30]]}}}